Aceto (ACET) Earns “Buy” Rating from Canaccord Genuity
Several other equities research analysts have also issued reports on ACET. Zacks Investment Research raised Aceto from a strong sell rating to a hold rating in a research note on Monday, October 30th. BidaskClub lowered Aceto from a sell rating to a strong sell rating in a research note on Friday, December 15th. Finally, ValuEngine lowered Aceto from a buy rating to a hold rating in a research note on Sunday, December 31st.
Aceto (ACET) opened at $7.43 on Monday. Aceto has a twelve month low of $7.20 and a twelve month high of $17.10. The company has a debt-to-equity ratio of 0.79, a current ratio of 2.00 and a quick ratio of 1.38. The company has a market capitalization of $223.64, a price-to-earnings ratio of -46.44, a PEG ratio of 0.71 and a beta of 1.40.
The firm also recently disclosed a quarterly dividend, which will be paid on Friday, March 23rd. Investors of record on Friday, March 9th will be paid a dividend of $0.065 per share. This represents a $0.26 annualized dividend and a yield of 3.50%. The ex-dividend date is Thursday, March 8th. Aceto’s dividend payout ratio is -162.50%.
A number of large investors have recently bought and sold shares of ACET. SG Americas Securities LLC bought a new stake in Aceto during the third quarter valued at $106,000. Teacher Retirement System of Texas bought a new stake in Aceto during the fourth quarter valued at $108,000. Palisade Capital Management LLC NJ bought a new stake in Aceto during the third quarter valued at $131,000. BNP Paribas Arbitrage SA boosted its stake in Aceto by 73.4% during the third quarter. BNP Paribas Arbitrage SA now owns 14,924 shares of the company’s stock valued at $168,000 after buying an additional 6,316 shares during the period. Finally, Hotchkis & Wiley Capital Management LLC bought a new stake in Aceto during the third quarter valued at $190,000. 78.41% of the stock is owned by institutional investors.
COPYRIGHT VIOLATION NOTICE: “Aceto (ACET) Earns “Buy” Rating from Canaccord Genuity” was first reported by Watch List News and is the sole property of of Watch List News. If you are reading this story on another publication, it was copied illegally and reposted in violation of U.S. and international trademark and copyright law. The original version of this story can be read at https://www.watchlistnews.com/aceto-acet-earns-buy-rating-from-canaccord-genuity/1853622.html.
Aceto Corporation (Aceto) is engaged in the marketing, sales and distribution of finished dosage form generic pharmaceuticals, nutraceutical products, pharmaceutical active ingredients and intermediates, specialty performance chemicals inclusive of agricultural intermediates and agricultural protection products.
Receive News & Ratings for Aceto Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aceto and related companies with MarketBeat.com's FREE daily email newsletter.